Acción A206640 BODITECH MED INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Boditech Med Inc.

Acciones

A206640

KR7206640005

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 13/05/2024 		Varia. Cinco días. Varia. 1 de enero.
16.530 KRW +3,05 % Gráfico intradía de Boditech Med Inc. +5,76 % -19,37 %
2023 Boditech Med Inc. y SphingoTec GmbH firman un acuerdo de desarrollo de mercado para impulsar la comercialización del biomarcador de la función renal penKid CI
2022 Boditech Med Inc. y SphingoTec GmbH firman un acuerdo de licencia no exclusiva por derechos de autor CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH'S AFIAS-10 SYSTEM
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Boditech Med Inc. authorizes a Buyback Plan.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America
Boditech Med to Expand to U.S., North America
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A206640
  4. Noticias Boditech Med Inc.
  5. Otros idiomas